Navigating 14 Analyst Ratings For AbbVie - Nasdaq

4 days ago  · Throughout the last three months, 14 analysts have evaluated AbbVie (NYSE:ABBV), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ...


Install CouponFollow Chrome Extension   CouponFollow Extension

$189
OFF

Analyst Scoreboard: 6 Ratings For AbbVie - Nasdaq

1 week from now

Jun 5, 2024  · 0. 0. 0. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $189.5, along with a high estimate of $200.00 and a low …

nasdaq.com

81%
OFF

AbbVie Inc. (ABBV) Analyst Ratings - Stock Analysis

1 week from now

Nov 5, 2024  · A list of analyst ratings for AbbVie (ABBV) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... +14.81%: Oct 31, 2024 : Andrew …

stockanalysis.com

$208.09
OFF

In-Depth Examination Of 11 Analyst Recommendations For …

1 week from now

Oct 7, 2024  · Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $208.09, accompanied by a high estimate of $225.00 and a low estimate of …

nasdaq.com

$209.73
OFF

Forecasting The Future: 11 Analyst Projections For AbbVie

1 week from now

Oct 25, 2024  · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $209.73, a high estimate of $225.00, and a low …

nasdaq.com

$188.29
OFF

The Latest Analyst Ratings For AbbVie | Markets Insider

1 week from now

Mar 22, 2024  · The 12-month price targets, analyzed by analysts, offer insights with an average target of $188.29, a high estimate of $195.00, and a low estimate of $175.00.

businessinsider.com

8%
OFF

The Analyst Verdict: AbbVie In The Eyes Of 5 Experts | Nasdaq

1 week from now

May 17, 2024  · Return on Equity (ROE): AbbVie's ROE excels beyond industry benchmarks, reaching 14.8%. This signifies robust financial management and efficient use of shareholder …

nasdaq.com

8%
OFF

Analyst Scoreboard: 6 Ratings For AbbVie | Markets Insider

1 week from now

Jun 5, 2024  · Stay up to date on AbbVie analyst ratings. ... With an impressive ROE of 14.8%, ... Nasdaq 100; Nasdaq Composite; FTSE 100; Nikkei 225; DAX 40; Hang Seng; Kospi;

businessinsider.com

$177.83
OFF

Analyst Ratings For AbbVie - Markets Insider

1 week from now

Dec 1, 2023  · According to 6 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $177.83 with a high of $196.00 and a low of $150.00.

businessinsider.com

$190.29
OFF

A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts

1 week from now

Jul 2, 2024  · 0. 0. Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $190.29, accompanied by a high estimate of $200.00 and a low estimate …

nasdaq.com

$171.57
OFF

Breaking Down AbbVie: 7 Analysts Share Their Views

1 week from now

Jan 23, 2024  · Insights from analysts' 12-month price targets are revealed, presenting an average target of $171.57, a high estimate of $196.00, and a low estimate of $150.00. Observing a …

businessinsider.com

$205
OFF

Wolfe Starts AbbVie At Outperform, Says Valuation An ... - Nasdaq

1 week from now

2 days ago  · Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded "quite confident" on immuno …

nasdaq.com

$314.73
OFF

A Glimpse Into The Expert Outlook On Duolingo Through 15 …

1 week from now

2 days ago  · Insights from analysts' 12-month price targets are revealed, presenting an average target of $314.73, a high estimate of $408.00, and a low estimate of $250.00.

nasdaq.com

45%
OFF

ABBV | AbbVie Inc. Analyst Estimates & Ratings – WSJ

1 week from now

AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... PRE MARKET 6:21 AM EST 11/14/24 $ 171.11 0.76 0.45%; ... Real-time U.S. stock quotes reflect trades …

wsj.com

$242.58
OFF

A Closer Look At 19 Analyst Recommendations For Atlassian

1 week from now

2 days ago  · In the assessment of 12-month price targets, analysts unveil insights for Atlassian, presenting an average target of $242.58, a high estimate of $300.00, and a low estimate of …

nasdaq.com

FAQs about Navigating 14 Analyst Ratings For AbbVie - Nasdaq Coupon?

How have analysts rated AbbVie (abbv)?

AbbVie (NYSE:ABBV) has observed the following analyst ratings within the last quarter: According to 6 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $177.83 with a high of $196.00 and a low of $150.00. Below is a summary of how these 6 analysts rated AbbVie over the past 3 months. ...

How many analysts recommend 'abbv' stock?

Based on 19 analysts offering recommendations for 'ABBV' in the last 3 months. Analyst price targets provided by TipRanks. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. ...

How do analysts evaluate AbbVie (ABV) stock?

Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of AbbVie's stock. This comparison reveals trends in analysts' expectations over time. Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of AbbVie's market position. ...

What do 'actual' numbers mean on abbv stock?

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ABBV updated stock price target summary. ...

How do analysts evaluate AbbVie's market position?

Price Targets: Analysts predict movements in price targets, offering estimates for AbbVie's future value. Examining the current and prior targets offers insights into analysts' evolving expectations. Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of AbbVie's market position. ...

Is AbbVie a good company?

Stay up to date on AbbVie analyst ratings. AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension